| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, Department of Medicine [C. B., E. P. G.] and Department of Biochemistry and Molecular Biology [S. S.], Lombardi Cancer Center, Georgetown University School of Medicine, Washington, DC 20007-2196
The role of the retinoblastoma gene product, RB, in transmitting the signals of apoptosis is unclear, but RB is considered to be antiapoptotic because RB mediates cell cycle arrest that also can interrupt intracellular signaling pathways leading to apoptosis.
-Radiation can cause apoptosis, the process of programmed cell death, via several mechanisms including DNA damage, ceramide production, and the generation of free radical oxygen species. We investigated the effect of RB on radiation-induced apoptosis by restoring normal RB expression in DU-145 prostate cancer cells that have one deleted and one truncated RB gene. DU-145 cells are highly resistant to apoptosis induced either by radiation or by the addition of ceramide. Two independently derived RB-positive DU-145 derivative cell lines underwent apoptosis after irradiation or exposure to the cell permeable C2-ceramide. Apoptosis in the RB-positive cell lines was not associated with major changes in the cell cycle response to irradiation. RB-mediated apoptosis occurred in the absence of expression of caspases 8, 6, 3, and 7 and without detectable cleavage of poly(ADP)ribose polymerase. However, a specific inhibitor of serine proteases, Na-p-Tosyl-L-lysyl- chloromethyl ketone, inhibited radiation-induced apoptosis in DU-145 cells expressing RB. Radiation-induced apoptosis was preceded by an increase in JUN protein expression and accompanied by activation of the stress-related JUN kinase. Our data show that RB is proapoptotic in DU-145 cells and acts upstream of JUN expression and JNK activation.
1 Supported by Research Grants CA57178 (to E. P. G.) and CA61774 (to S. S.) from the National Cancer Institute, Grant BE-275 from The American Cancer Society (to S. S.), and an award from the CaPCURE Foundation. The Lombardi Cancer Center Flow Cytometry Core is supported by Grant CA51008 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Lombardi Cancer Center, 3800 Reservoir Road, NW, Washington, DC 20007-2197. Phone: (202) 687-2207; Fax: (202) 784-1229; E-mail: gelmanne@gunet.georgetown.edu.
Received 2/13/98. Accepted 6/ 2/98.
This article has been cited by other articles:
![]() |
X. Wang, H. Deng, I. Basu, and L. Zhu Induction of Androgen Receptor-Dependent Apoptosis in Prostate Cancer Cells by the Retinoblastoma Protein Cancer Res., February 15, 2004; 64(4): 1377 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, M. Li, H. Wang, S. Agrawal, and R. Zhang Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy PNAS, September 30, 2003; 100(20): 11636 - 11641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellan, G. De Falco, G. M. Tosi, S. Lazzi, F. Ferrari, G. Morbini, S. Bartolomei, P. Toti, P. Mangiavacchi, G. Cevenini, et al. Missing Expression of pRb2/p130 in Human Retinoblastomas Is Associated with Reduced Apoptosis and Lesser Differentiation Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3602 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bowen, M. Birrer, and E. P. Gelmann Retinoblastoma Protein-mediated Apoptosis After gamma -Irradiation J. Biol. Chem., November 15, 2002; 277(47): 44969 - 44979. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kimura, M. Markowski, C. Bowen, and E. P. Gelmann Androgen Blocks Apoptosis of Hormone-dependent Prostate Cancer Cells Cancer Res., July 1, 2001; 61(14): 5611 - 5618. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abate-Shen and M. M. Shen Molecular genetics of prostate cancer Genes & Dev., October 1, 2000; 14(19): 2410 - 2434. [Full Text] |
||||
![]() |
V. E. Nava, O. Cuvillier, L. C. Edsall, K. Kimura, S. Milstien, E. P. Gelmann, and S. Spiegel Sphingosine Enhances Apoptosis of Radiation-resistant Prostate Cancer Cells Cancer Res., August 1, 2000; 60(16): 4468 - 4474. [Abstract] [Full Text] |
||||
![]() |
M. Garzotto, A. Haimovitz-Friedman, W.-C. Liao, M. White-Jones, R. Huryk, W. D. W. Heston, C. Cardon-Cardo, R. Kolesnick, and Z. Fuks Reversal of Radiation Resistance in LNCaP Cells by Targeting Apoptosis through Ceramide Synthase Cancer Res., October 1, 1999; 59(20): 5194 - 5201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Mack, D. R. Gandara, C. Bowen, M. J. Edelman, T. Paglieroni, J. B. Schnier, E. P. Gelmann, and P. H. Gumerlock RB Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma Clin. Cancer Res., September 1, 1999; 5(9): 2596 - 2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kimura, C. Bowen, S. Spiegel, and E. P. Gelmann Tumor Necrosis Factor-{{alpha}} Sensitizes Prostate Cancer Cells to {{gamma}}-Irradiation-induced Apoptosis Cancer Res., April 1, 1999; 59(7): 1606 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chauhan, T. Hideshima, S. Treon, G. Teoh, N. Raje, S. Yoshihimito, Y.-T. Tai, W. Li, J. Fan, J. DeCaprio, et al. Functional Interaction between Retinoblastoma Protein and Stress-activated Protein Kinase in Multiple Myeloma Cells Cancer Res., March 1, 1999; 59(6): 1192 - 1195. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |